Handelsavisen
prelaunch
Companies Industrials HCSG.O
HC
HCSG.O NASDAQ Commercial Services & Supplies

Hcsg.O

$23,41
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
1,6B USD
P/E
13,4x
EV / Rev
0,8x
Div yield
Op margin
6,9 %
ROE
24,1 %
Net margin
6,6 %
Debt / equity
Beta
52w range
Volume
Day range
Prev close
$23,75
Open
Next earnings
2026-10-28
Ex-dividend
TR 1Y
About

Healthcare Services Group operates in the multiline insurance and brokerage sector, generating revenue through insurance services and related commercial activities.

Business. Healthcare Services Group operates in the multiline insurance and brokerage sector, generating revenue through insurance services and related commercial activities.

Classification85 %
SectorIndustrials
Industry groupCommercial Services & Supplies
Generated · model-assisted
Sell-side consensus
BUY6 analysts
3 buy3 hold0 sell
Avg 12m price target26,80

Analyst recommendations

6 analysts · consensus Buy
Buy3
Hold3
Sell0
12-month price target
26,80
Consensus of sell-side coverage.
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
13,4x
P/E
Analysts
Buy
6 analysts · indicative
Ownership
American Century Investment Management, Inc.
largest disclosed fund holder
Profitability
24,1 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning HCSG.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials · THIS SECTOR−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to HCSG.O. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Healthcare Services Group operates in the multiline insurance and brokerage sector, generating revenue through insurance services and related commercial activities.

    Classification85 %
    SectorIndustrials
    Industry groupCommercial Services & Supplies
    AI synthesis
    GENERATED

    The company maintains a conservative capital structure with a debt-to-equity ratio of 0.0, indicating no recorded interest-bearing debt on the balance sheet. Liquidity is supported by cash and equivalents of $125.2 million against total assets of $794.3 million, resulting in a low liquidity risk assessment. The firm generates robust operating cash flow of $145.0 million, which significantly exceeds its capital expenditure of $5.8 million, providing ample free cash flow for operations or potential return of capital.

    Profitability metrics demonstrate strong returns, with a return on equity of 24.1% and a return on assets of 15.5%. The net income of $59.1 million on revenue of $1.84 billion yields a net margin of approximately 3.2%. While specific cohort median comparisons are absent from the input data, the high ROE and ROA suggest efficient capital utilization relative to typical insurance industry benchmarks. The valuation snapshot shows a price-to-earnings ratio of 13.44 and a price-to-book ratio of 3.24, reflecting a premium valuation relative to book value but a moderate multiple on earnings.

    Key takeaways
    • The company operates with zero debt, resulting in a debt-to-equity ratio of 0.0 and eliminating interest rate risk.
    • Strong profitability is evidenced by a 24.1% return on equity and 15.5% return on assets.
    • Operating cash flow of $145.0 million significantly exceeds capital expenditures of $5.8 million, generating substantial free cash flow.
    • Analyst consensus suggests upside potential, with a mean price target of $26.80 versus the current price of $23.75.
    • Dilution risk is assessed as low, with no difference between basic and diluted shares outstanding.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-07-22
    Q2 2026 · Quarter highlights

    Revenue $470.8M, +2,7% YoY; Operating income +148,1% YoY.

    Revenue$470.8M+2,7 % YoY
    Operating income$22.2M+148,1 % YoY
    Net income$22.7M+170,1 % YoY
    Free cash flow$24.6M+185,6 % YoY
    EPS
    Operating cash flow$65.6M+16,5 % YoY
    Financials
    Income statement
    Revenue$470.8M
    Gross profit$74.8M
    Operating income$22.2M
    Net income$22.7M
    Margins
    Gross margin15.9%
    Operating margin4.7%
    Net margin4.8%
    FCF margin5.2%
    Balance sheet
    Total assets$820.9M
    Total liabilities$302.0M
    Total equity$518.8M
    Cash & equivalents$123.4M
    Long-term debt$0.00
    Cash flow
    Operating cash flow$65.6M
    CapEx-$3.0M
    Free cash flow$24.6M
    SBC
    P&L flow · revenue → net income
    Revenue $470.8MOperating costs $448.6MNet income $22.7M
    Highlights
    • Revenue $470.8M, +2,7% YoY
    • Operating income +148,1% YoY
    • Net income +170,1% YoY
    • Free cash flow +185,6% YoY
    • Net margin 4.8%

    Valuation TTM

    Market price
    $23,41
    Market cap
    $1.65B
    Enterprise value
    $1.53B
    P/E
    13.4x
    Non-GAAP P/E
    EV / Revenue
    0.8x
    EV / Op income
    12.0x
    EV / OCF
    10.5x
    P / B
    3.2x
    P / Tangible book
    Tangible book
    Net cash
    $125.2M
    Current ratio
    Debt / equity
    ROA
    15.5%
    ROE
    24.1%
    Cash conversion
    118.0%
    CapEx / revenue
    -0.3%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    Business relationships12 disclosed relationships · 1 type · extracted from filings & disclosures
    Subsidiaries12
    EX21:19e21c6db34eEX21:19e21c6db34eSubsidiarie97%
    EX21:40d404155778EX21:40d404155778Subsidiarie97%
    EX21:6a3bdff6509cEX21:6a3bdff6509cSubsidiarie97%
    EX21:6f4131b52fa1EX21:6f4131b52fa1Subsidiarie97%
    EX21:7616b9d75258EX21:7616b9d75258Subsidiarie97%
    EX21:763d7072b698EX21:763d7072b698Subsidiarie97%
    EX21:7c8213549c45EX21:7c8213549c45Subsidiarie97%
    EX21:90e5f240aa90EX21:90e5f240aa90Subsidiarie97%
    EX21:b5e1c1e1f4fbEX21:b5e1c1e1f4fbSubsidiarie97%
    EX21:b938d18e1effEX21:b938d18e1effSubsidiarie97%
    EX21:c585ffdbf9daEX21:c585ffdbf9daSubsidiarie97%
    EX21:d6971a1560eeEX21:d6971a1560eeSubsidiarie97%

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    1,13
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    6
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-07-29 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate1,13
    Revenueno estimateno estimate1,9B USD
    Operating incomeno estimateno estimate104,6M USD
    Full-year consensus mean (period as reported by source) · consensus in USD. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution6 analysts
    Strong buy1
    Buy2
    Hold3
    Sell0
    Strong sell0
    12-month price target$26,80 · Median $26,00
    Low $24,00High $30,00
    Operating income · consensus104,6M USD
    EPS surprise
    −28,4 %
    reported vs consensus · miss
    Revenue surprise
    −4,4 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$24,00
    Mean$26,80
    Median$26,00
    High$30,00
    Spot$23,41
    +14.5 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin6,9 %Below median
    Net Margin6,6 %Below median
    ROE24,1 %Best in class
    Capex / Rev-0,3 %Above median
    D/E0,00Above median
    Cash Conv1,18Below median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    Derivative transactions

    Net disposed 112 904 sh20 exercises · 5 grants6 insiders
    • Singh VikasEVP & Chief Financial Officer · Restricted Stock Units → Common StockDisposed 935exercise · 2026-05-27
    • Singh VikasEVP & Chief Financial Officer · Restricted Stock Units → Common StockAcquired 2 202grant · 2026-05-27
    • SHEA JOHN CHRISTOPHEREVP & Chief Admin. Officer · Restricted Stock Units → Common StockDisposed 4 416exercise · 2026-02-24
    • Bundick Jason JEVP/Gen. Counsel/Corp. Secty. · Restricted Stock Units → Common StockDisposed 3 374exercise · 2026-02-24
    • WAHL TheodoreDirector, President & CEO · Restricted Stock Units → Common StockDisposed 22 238exercise · 2026-02-24
    • Kush AndrewEVP & Chief Operating Officer · Restricted Stock Units → Common StockDisposed 4 416exercise · 2026-02-24
    • Orr Patrick JEVP & Chief Revenue Officer · Restricted Stock Units → Common StockDisposed 3 340exercise · 2026-02-24
    • Orr Patrick JEVP & Chief Revenue Officer · Stock Option (right to buy) → Common StockDisposed 21 075 @ $18,10exercise · 2026-02-18
    • SHEA JOHN CHRISTOPHEREVP & Chief Admin. Officer · Stock Option (right to buy) → Common StockDisposed 29 579 @ $18,10exercise · 2026-02-18
    • SHEA JOHN CHRISTOPHEREVP & Chief Admin. Officer · Stock Option (right to buy) → Common StockDisposed 9 278 @ $13,72exercise · 2026-02-18
    • Orr Patrick JEVP & Chief Revenue Officer · Stock Option (right to buy) → Common StockDisposed 12 216 @ $10,36exercise · 2026-02-18
    • Orr Patrick JEVP & Chief Revenue Officer · Stock Option (right to buy) → Common StockDisposed 7 016 @ $13,72exercise · 2026-02-18
    • Orr Patrick JEVP & Chief Revenue Officer · Stock Option (right to buy) → Common StockDisposed 5 193 @ $11,76exercise · 2026-02-18
    • SHEA JOHN CHRISTOPHEREVP & Chief Admin. Officer · Restricted Stock Units → Common StockAcquired 18 832grant · 2026-01-05
    • Orr Patrick JEVP & Chief Revenue Officer · Restricted Stock Units → Common StockAcquired 18 852grant · 2026-01-05
    • SHEA JOHN CHRISTOPHEREVP & Chief Admin. Officer · Restricted Stock Units → Common StockDisposed 2 002exercise · 2026-01-04
    • SHEA JOHN CHRISTOPHEREVP & Chief Admin. Officer · Restricted Stock Units → Common StockDisposed 3 317exercise · 2026-01-04
    • Orr Patrick JEVP & Chief Revenue Officer · Restricted Stock Units → Common StockDisposed 2 363exercise · 2026-01-04
    • Orr Patrick JEVP & Chief Revenue Officer · Restricted Stock Units → Common StockDisposed 1 498exercise · 2026-01-04
    • SHEA JOHN CHRISTOPHEREVP & Chief Admin. Officer · Restricted Stock Units → Common StockDisposed 6 345exercise · 2026-01-03
    • SHEA JOHN CHRISTOPHEREVP & Chief Admin. Officer · Restricted Stock Units → Common StockDisposed 5 683exercise · 2026-01-03
    • Orr Patrick JEVP & Chief Revenue Officer · Restricted Stock Units → Common StockDisposed 5 373exercise · 2026-01-03
    • Orr Patrick JEVP & Chief Revenue Officer · Restricted Stock Units → Common StockDisposed 5 970exercise · 2026-01-03
    • Orr Patrick JEVP & Chief Revenue Officer · Phantom Stock → Common StockAcquired 1 444grant · 2025-12-31
    • SHEA JOHN CHRISTOPHEREVP & Chief Admin. Officer · Phantom Stock → Common StockAcquired 1 393grant · 2025-12-31

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Reference data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Ev To Revenue
      enterprise_value / revenue
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Return On Equity
      net_income / total_equity
    • Market Cap
      market_price * shares_outstanding_diluted
    Source documents
    • HEALTHCARE SERVICES GROUP, INC. Market data — financials · 2026-07-29
    • reconciler_enqueue (reconciler) on HCSG.O · 2026-07-29
    • Healthcare Services Group Inc Market data — analyst estimates · 2026-07-29
    • Healthcare Services Group Inc Market data — ESG · 2026-07-29
    • HCSG.O HA canonical relationships · 2026-07-29

    Ownership & reference

    Top holders

    • American Century Investment Management, Inc.Investment Managers · as of 2026-03-310,02 %$47M
    • Arrowstreet Capital, Limited PartnershipInvestment Managers · as of 2026-03-310,01 %$26M
    • AMERIPRISE FINANCIAL INCInstitutional Investor · as of 2026-03-310,01 %$40M
    • Dimensional Fund Advisors, L.P.Investment Managers · as of 2026-03-310,01 %$45M
    • AQR Capital Management, LLCInvestment Managers · as of 2026-03-310,01 %$20M
    • JANUS HENDERSON GROUP PLCInstitutional Investor · as of 2026-03-310,01 %$17M
    • Franklin Advisers, Inc.Investment Managers · as of 2026-03-310,01 %$22M
    • Principal Global Investors (Equity)Investment Managers · as of 2026-03-310,00 %$9M
    • Charles Schwab Investment Management, Inc.Investment Managers · as of 2026-03-310,00 %$25M
    • BlackRock Institutional Trust Company, N.A.Investment Managers · as of 2024-06-300,00 %$135M
    • Raymond James & Associates, Inc.Brokerage Firms · as of 2026-03-310,00 %$10M
    • Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,00 %$22M
    • Nuveen LLCInvestment Managers · as of 2024-12-310,00 %$10M
    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,00 %$38M
    • Invesco QQQ TrustFunds · as of 2026-03-310,00 %$15M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,00 %$154M
    • FMR LLCInstitutional Investor · as of 2026-03-310,00 %$36M
    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,00 %$52M
    • AllianceBernstein L.P.Investment Managers · as of 2026-03-310,00 %$5M
    • Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,00 %$13M
    • Bank of New York Mellon CorpInstitutional Investor · as of 2026-03-310,00 %$8M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,00 %$19M
    • Victory Capital Management Inc.Investment Managers · as of 2026-03-310,00 %$1M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,00 %$2M
    • T. Rowe Price Associates, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Wells Fargo AdvisorsBrokerage Firms · as of 2026-03-310,00 %$1M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$0M

    Leadership

    • Theodore WahlPresident, Chief Executive Officer, Director

    Insider activity

    Net selling0 buys · 6 sellsnet -$3,0M14 insiders · last 365d
    • Brophy Andrew MSVP & Chief Accounting Officer · Common StockOther 4 381 · 2026-07-01
    • WHALEN THOMAS GERARDDirector · Common StockOther 102 @ $24,56$3K · 2026-06-30
    • Grant Laura KDirector · Common StockOther 306 @ $24,56$8K · 2026-06-30
    • Simmons Kurt JRDirector · Common StockOther 611 @ $24,56$15K · 2026-06-30
    • Casey Diane SDirector · Common StockOther 1 969 @ $20,32$40K · 2026-05-26
    • WHALEN THOMAS GERARDDirector · Common StockOther 1 969 @ $20,32$40K · 2026-05-26
    • Gallagher Thomas MichaelDirector · Common StockOther 1 969 @ $20,32$40K · 2026-05-26
    • Ottaviano Dino DDirector · Common StockOther 1 969 @ $20,32$40K · 2026-05-26
    • Simmons Kurt JRDirector · Common StockOther 1 969 @ $20,32$40K · 2026-05-26
    • Grant Laura KDirector · Common StockOther 1 969 @ $20,32$40K · 2026-05-26
    • Visconto JudeDirector · Common StockOther 1 969 @ $20,32$40K · 2026-05-26
    • Castagnino DanielaDirector · Common StockOther 1 969 @ $20,32$40K · 2026-05-26
    • Simmons Kurt JRDirector · Common StockOther 809 @ $18,55$15K · 2026-03-31
    • Grant Laura KDirector · Common StockOther 405 @ $18,55$8K · 2026-03-31
    • WHALEN THOMAS GERARDDirector · Common StockOther 135 @ $18,55$3K · 2026-03-31
    • Brophy Andrew MSVP & Chief Accounting Officer · Common StockSold 2 490 @ $21,75$54K · 2026-02-26
    • Kush AndrewEVP & Chief Operating Officer · Common StockOther 4 416 · 2026-02-24
    • Kush AndrewEVP & Chief Operating Officer · Common StockOther 1 874 @ $21,40$40K · 2026-02-24
    • Kush AndrewEVP & Chief Operating Officer · Common StockOther 12 618 · 2026-02-24
    • Kush AndrewEVP & Chief Operating Officer · Common StockOther 5 353 @ $21,40$115K · 2026-02-24
    • Orr Patrick JEVP & Chief Revenue Officer · Common StockOther 3 340 · 2026-02-24
    • Orr Patrick JEVP & Chief Revenue Officer · Common StockOther 1 417 @ $21,40$30K · 2026-02-24
    • Orr Patrick JEVP & Chief Revenue Officer · Common StockOther 9 543 · 2026-02-24
    • Orr Patrick JEVP & Chief Revenue Officer · Common StockOther 4 049 @ $21,40$87K · 2026-02-24
    • WAHL TheodoreDirector, President & CEO · Common StockOther 22 238 · 2026-02-24

    Short positioning

    2.2Mshares short-18.5% vs prior
    3.83days to cover
    57.0%short of daily vol
    39fails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    HCSG.OCanonical
    NASDAQ · USD

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.
    Relationship graph
    HCSGEX21:19eEX21:40dEX21:6a3EX21:6f4EX21:761EX21:763EX21:7c8EX21:90eEX21:b5eEX21:b93Commercial Ser
    This companySectorSubsidiaries

    Evidence & claims

    From filings & derived data
    • Capex (annual): USD 5.82MUnknown
    • Current assets (annual): USD 576.41MUnknown
    • EPS (basic) (annual): USD-PER-SHARES 1Unknown
    • Current liabilities (annual): USD 170.38MUnknown
    • EPS (diluted) (annual): USD-PER-SHARES 1Unknown
    • Shareholders' equity (annual): USD 510.21MUnknown
    • Total assets (annual): USD 794.25MUnknown
    • Shares outstanding (annual): 69.6MUnknown
    • Cash & equivalents (annual): USD 125.19MUnknown
    • Cost of revenue (annual): USD 1.6BUnknown
    • Revenue (annual): USD 1.84BUnknown
    • Operating cash flow (annual): USD 144.97MUnknown
    • Pre-tax income (annual): USD 67.87MUnknown
    • Net income (annual): USD 59.06MUnknown
    • Pre-tax income (annual): USD 52.94MUnknown
    • Cash & equivalents (annual): USD 56.78MUnknown
    • Net income (annual): USD 39.47MUnknown
    • Cost of revenue (annual): USD 1.49BUnknown
    • Capex (annual): USD 6.34MUnknown
    • Total assets (annual): USD 802.77MUnknown
    • Current assets (annual): USD 556.65MUnknown
    • Shares outstanding (annual): 73.2MUnknown
    • Operating cash flow (annual): USD 30.8MUnknown
    • Revenue (annual): USD 1.72BUnknown
    Showing 24 of 26 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    2026-07-22 07:01 UTCEARNINGSQuarterly results — Q2 2026 Revenue USD 470.8M · Net USD 22.7M
    2026-07-22 00:00 UTCTRANSCRIPTEarnings call — Q3 2026
    2026-07-22EVENTQ2 2026 earnings (expected) estimated date
    2026-07-01INSIDERBrophy Andrew M transacted 4.4k sh — SVP & Chief Accounting Officer
    2026-06-30INSIDERWHALEN THOMAS GERARD transacted 102 sh — Director ~$3k
    2026-06-30INSIDERGrant Laura K transacted 306 sh — Director ~$8k
    2026-06-30INSIDERSimmons Kurt JR transacted 611 sh — Director ~$15k
    2026-05-27 00:00 UTCINSIDER10 insider transactions — 2026-05 · net buy $320k 2 derivative
    2026-05-27 00:00 UTCINSIDER10 insider transactions — 2026-05 · net buy $320k 2 derivative
    2026-05-27FILING8-K filing →
    2026-05-27INSIDERSingh Vikas acquired 2.2k sh Restricted Stock Units — EVP & Chief Financial Officer
    2026-05-27INSIDERSingh Vikas disposed of 935 sh Restricted Stock Units — EVP & Chief Financial Officer
    2026-05-26INSIDERCasey Diane S transacted 2.0k sh — Director ~$40k
    2026-05-26INSIDERWHALEN THOMAS GERARD transacted 2.0k sh — Director ~$40k
    2026-05-26INSIDERGallagher Thomas Michael transacted 2.0k sh — Director ~$40k
    2026-05-26INSIDEROttaviano Dino D transacted 2.0k sh — Director ~$40k
    2026-05-26INSIDERSimmons Kurt JR transacted 2.0k sh — Director ~$40k
    2026-05-26INSIDERGrant Laura K transacted 2.0k sh — Director ~$40k
    2026-05-26INSIDERVisconto Jude transacted 2.0k sh — Director ~$40k
    2026-05-26INSIDERCastagnino Daniela transacted 2.0k sh — Director ~$40k
    2026-04-24FILING10-Q filing →
    2026-04-22 07:00 UTCEARNINGSQuarterly results — Q1 2026 Revenue USD 462.8M · Net USD 26.1M
    2026-04-22FILING8-K filing →
    2026-04-15FILINGDEF 14A filing →
    2026-04-13FILING8-K filing →
    2026-03-31 00:00 UTCINSIDER3 insider transactions — 2026-03
    2026-03-31 00:00 UTCINSIDER3 insider transactions — 2026-03
    2026-03-31INSIDERSimmons Kurt JR transacted 809 sh — Director ~$15k
    2026-03-31INSIDERGrant Laura K transacted 405 sh — Director ~$8k
    2026-03-31INSIDERWHALEN THOMAS GERARD transacted 135 sh — Director ~$3k
    2026-02-26 00:00 UTCINSIDER46 insider transactions — 2026-02 · net sell $3.0M 11 derivative
    2026-02-26 00:00 UTCINSIDER46 insider transactions — 2026-02 · net sell $3.0M 11 derivative
    2026-02-26INSIDERBrophy Andrew M sold 2.5k sh — SVP & Chief Accounting Officer ~$54k
    2026-02-24INSIDERKush Andrew transacted 4.4k sh — EVP & Chief Operating Officer
    2026-02-24INSIDERKush Andrew transacted 1.9k sh — EVP & Chief Operating Officer ~$40k
    2026-02-24INSIDERKush Andrew transacted 12.6k sh — EVP & Chief Operating Officer
    2026-02-24INSIDERKush Andrew transacted 5.4k sh — EVP & Chief Operating Officer ~$115k
    2026-02-24INSIDEROrr Patrick J transacted 3.3k sh — EVP & Chief Revenue Officer
    2026-02-24INSIDEROrr Patrick J transacted 1.4k sh — EVP & Chief Revenue Officer ~$30k
    Showing the 40 most recent of 76 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Reference data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage